Zura Bio Announces Closing of its $144 Million Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares
ZuraZura(US:ZURA) Businesswire·2026-02-27 19:30

公司融资活动 - Zura Bio Limited 于2026年2月26日完成了此前宣布的承销公开发行，发行了21,200,000股A类普通股及预融资权证 [1] 公司业务定位 - 公司是一家临床阶段生物技术公司，致力于开发新颖且差异化的药物，以有意义地改善患有严重且致衰性自身免疫及炎症性疾病患者的生活 [1]

Zura Bio Announces Closing of its $144 Million Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares - Reportify